FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Wang

Research Profile

Disorders

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Anatomy

Tumor Cell Line

Concepts & Ideas

Living Beings

Physiology

Cell Proliferation

Co-author Network

Publications

TOP 3
Raymond Alexanian; Kay Delasalle; Michael Wang
High frequencies of response after limited primary therapy for multiple myeloma.
Kejie Zhang; Liang Zhang; Richard J Ford; Michael Kauffman; John Lee; Changping Li; Zhishuo Ou; Sharon Shacham; Luhong Sun; Archito T Tamayo; Michael Wang; Lan V Pham
Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma.
Ke-Jie Zhang; Michael Wang
Potential effects of CRM1 inhibition in mantle cell lymphoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Wang (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Raymond Alexanian; Kay Delasalle; Michael Wang
High frequencies of response after limited primary therapy for multiple myeloma.
Clinical lymphoma, myeloma & leukemia 2013;13(2):119-22.
2013: Kejie Zhang; Liang Zhang; Richard J Ford; Michael Kauffman; John Lee; Changping Li; Zhishuo Ou; Sharon Shacham; Luhong Sun; Archito T Tamayo; Michael Wang; Lan V Pham
Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma.
Experimental hematology 2013;41(1):67-78.e4.
2012: Ke-Jie Zhang; Michael Wang
Potential effects of CRM1 inhibition in mantle cell lymphoma.
Chinese journal of cancer research = Chung-kuo yen cheng yen chiu 2012;24(4):374-87.
2012: Liang Zhang; Larry W Kwak; Haiyan Li; Jianfei Qian; Jorge Romaguera; Michael Wang; Jing Yang; Qing Yi
Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells.
Blood 2012;120(18):3783-92.
2012: Deborah J. Kuhn; Pei Lin; Wencai Ma; Timothy L Madden; Veerabhadran Baladandayuthapani; Zuzana Berkova; Chad C Bjorklund; R Eric Davis; Richard J Jones; Jatin J Shah; Sheeba K Thomas; Hua Wang; Michael Wang; Donna M Weber; Caimiao Wei; Richard Woessner; Robert Z Orlowski
Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma.
Blood 2012;120(16):3260-70.
2012: Michael Wang; Anas Younes; Ken H Young; Jerome Zeldis; Liang Zhang; Felipe Samaniego; Luhong Sun; Nicolaus Wagner-Bartak; Maria Badillo; Maria Bejarano; Neda Bell; Catriona Byrne; Fernando Cabanillas; Richard Champlin; Wendy Chen; Yiming Chen; Michelle A Fanale; Luis Fayad; Lei Feng; Nathan Fowler; Fredrick Hagemeister; Kimberly Hartig; Larry W Kwak; Peter McLaughlin; Sattva S Neelapu; Kate J Newberry; Jorge Romaguera
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial.
The lancet oncology 2012;13(7):716-23.
2012: Xiaoying Liu; John Minna; Jack A Roth; Stephen G Swisher; Ji Wang; Li Wang; Michael Wang; Shuhong Wu; Luc Girard; Wei Guo; John V Heymach; Edward S Kim; Bingbing Dai; Bingliang Fang
Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells.
Biochemical pharmacology 2012;83(10):1456-64.
2012: Qaiser Bashir; Richard E Champlin; Yvonne T Dinh; Sergio Giralt; Chitra Hosing; Hassan Khan; Robert Z Orlowski; Simrit Parmar; Uday Popat; Sofia R Qureshi; Gabriela Rondon; Jatin J Shah; Nina Shah; Sheeba K Thomas; Michael Wang; Donna M Weber; Wei Wei; Ali Imran Amjad; Paolo Anderlini; Muzaffar H Qazilbash
Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
American journal of hematology 2012;87(3):272-6.
2012: Luhong Sun; Wenli Dong; Jianfei Qian; Jing Yang; Qing Yi; Liang Zhang; Michael Wang
Combination of atiprimod and the proteasome inhibitor bortezomib induces apoptosis of mantle cell lymphoma in vitro and in vivo.
Leukemia research 2012;36(3):363-8.
2012: Raymond Alexanian; Kay Delasalle; Sheeba Thomas; Michael Wang; Donna Weber
Curability of multiple myeloma.
Bone marrow research 2012;2012():916479.
2011: Richard J Jones; Sattva S Neelapu; Veerabhadran Baladandayuthapani; Luis Fayad; Jorge Romaguera; Rakesh Sharma; Michael Wang; Dajun Yang; Robert Z Orlowski
HDM-2 inhibition suppresses expression of ribonucleotide reductase subunit M2, and synergistically enhances gemcitabine-induced cytotoxicity in mantle cell lymphoma.
Blood 2011;118(15):4140-9.
2011: Lin Yang; Huamin Wang; Steven M Kornblau; D A Graber; Nianxiang Zhang; J A Matthews; Michael Wang; D M Weber; S K Thomas; J J Shah; LI Zhang; G Lu; Ming Zhao; R Muddasani; S-Y Yoo; Keith A Baggerly; Robert Z Orlowski
Evidence of a role for the novel zinc-finger transcription factor ZKSCAN3 in modulating Cyclin D2 expression in multiple myeloma.
Oncogene 2011;30(11):1329-40.
2011: Sally A Hunsucker; Valeria Magarotto; Deborah J. Kuhn; Steven M Kornblau; Michael Wang; Donna M Weber; Sheeba K Thomas; Jatin J Shah; Peter M Voorhees; Hong Xie; Mark Cornfeld; Jeffrey A Nemeth; Robert Z Orlowski
Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma.
British journal of haematology 2011;152(5):579-92.
2011: Zhengzi Qian; Liang Zhang; Zhen Cai; Luhong Sun; Huaqing Wang; Qing Yi; Michael Wang
Lenalidomide synergizes with dexamethasone to induce growth arrest and apoptosis of mantle cell lymphoma cells in vitro and in vivo.
Leukemia research 2011;35(3):380-6.
2010: William A Ross; Chukwuma I Egwim; Michael J Wallace; Michael Wang; David C Madoff; Jeffrey H Lee
Outcomes in lymphoma patients with obstructive jaundice: a cancer center experience.
Digestive diseases and sciences 2010;55(11):3271-7.
2010: Wencai Ma; Michael Wang; Zhi-Qiang Wang; Luhong Sun; David Graber; Jairo Matthews; Richard Champlin; Qing Yi; Robert Z Orlowski; Larry W Kwak; Donna M Weber; Sheeba K Thomas; Jatin Shah; Steven Kornblau; Richard E Davis
Effect of long-term storage in TRIzol on microarray-based gene expression profiling.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010;19(10):2445-52.
2010: Jorge Romaguera; Luis Fayad; Peter McLaughlin; Barbara Pro; Alma Rodriguez; Michael Wang; Pamela Weaver; Kimberly Hartig; Larry W Kwak; Tatyana Feldman; Judy Smith; Peggy Ford; Stuart Goldberg; Andrew Pecora; Andre Goy
Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma.
British journal of haematology 2010;151(1):47-53.
2010: Jean-Luc Harousseau; Meletios A Dimopoulos; Michael Wang; Alessandro Corso; Christine Chen; Michel Attal; Andrew Spencer; Zhinuan Yu; Marta Olesnyckyj; Jerome B Zeldis; Robert D Knight; Donna M Weber
Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma.
Haematologica 2010;95(10):1738-44.
2010: Yvonne A Efebera; Sofia R Qureshi; Suzanne M Cole; Rima M Saliba; Matteo Pelosini; Ronak M Patel; Ebru Koca; Floralyn Mendoza; Michael Wang; Jatin Shah; Amin Alousi; Chitra Hosing; Uday Popat; Partow Kebriaei; Paolo Anderlini; Issa F Khouri; Richard Champlin; Sergio Giralt; Muzaffar H Qazilbash
Reduced-intensity allogeneic hematopoietic stem cell transplantation for relapsed multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(8):1122-9.
2010: Jorge Romaguera; Luis Fayad; Lei Feng; Kimberly Hartig; Pamela Weaver; Maria Alma Rodriguez; Fredrick B Hagemeister; Barbara Pro; Peter McLaughlin; Anas Younes; Felipe Samaniego; Andre Goy; Fernando Cabanillas; Andrew Lamb; Larry Kwak; Michael Wang
Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma.
British journal of haematology 2010;150(2):200-8.
2010: Michael Wang; Kay Delasalle; Sergio Giralt; Raymond Alexanian
Rapid control of previously untreated multiple myeloma with bortezomib-lenalidomide-dexamethasone (BLD).
Hematology (Amsterdam, Netherlands) 2010;15(2):70-3.
2009: Michael Wang; Yasuhiro Oki; Barbara Pro; Jorge Romaguera; Maria Alma Rodriguez; Felipe Samaniego; Peter McLaughlin; Fredrick Hagemeister; Sattva S Neelapu; Amanda Copeland; Barry Samuels; Evelyne M Loyer; Yuan Ji; Anas Younes
Phase II study of yttrium-90-ibritumomab tiuxetan in patients with relapsed or refractory mantle cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5213-8.
2009: Jianfei Qian; Sungyoul Hong; Siqing Wang; Liang Zhang; Luhong Sun; Michael Wang; Jing Yang; Larry W Kwak; Jian Hou; Qing Yi
Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.
Blood 2009;114(18):3880-9.
2009: Yuhuan Zheng; Zhen Cai; Siqing Wang; Xiang Zhang; Jianfei Qian; Sungyoul Hong; Haiyan Li; Michael Wang; Jing Yang; Qing Yi
Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis.
Blood 2009;114(17):3625-8.
2009: Liang Zhang; Zhengzi Qian; Zhen Cai; Luhong Sun; Huaqing Wang; J Blake Bartlett; Qing Yi; Michael Wang
Synergistic antitumor effects of lenalidomide and rituximab on mantle cell lymphoma in vitro and in vivo.
American journal of hematology 2009;84(9):553-9.
2009: Gaurav C Parikh; Ali Imran Amjad; Rima M Saliba; Syed M A Kazmi; Ziad U Khan; Amit Lahoti; Chitra Hosing; Floralyn Mendoza; Suhail R Qureshi; Donna M Weber; Michael Wang; Uday Popat; Amin Alousi; Richard E Champlin; Sergio Giralt; Muzaffar H Qazilbash
Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(7):812-6.
2009: Michael Wang; Lily Sun; Jianfei Qian; X Han; Liang Zhang; Pei Lin; Z Cai; Qing Yi
Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy.
Leukemia 2009;23(7):1320-8.
2009: Uday Popat; Rima M Saliba; Rupinderjit Thandi; Chitra Hosing; Muzaffar H Qazilbash; Paolo Anderlini; Elizabeth J Shpall; John McMannis; Martin Körbling; Amin Alousi; Borje Andersson; Yago Nieto; Partow Kebriaei; Issa Khouri; Marcos De Lima; Donna Weber; Sheeba Thomas; Michael Wang; Roy Jones; Richard Champlin; Sergio Giralt
Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):718-23.
2008: Muzaffar H Qazilbash; Rima M Saliba; Yago Nieto; Gaurav Parikh; Matteo Pelosini; Fatima B Khan; Roy B Jones; Chitra Hosing; Floralyn Mendoza; Donna M Weber; Michael Wang; Uday Popat; Amin Alousi; Paolo Anderlini; Richard E Champlin; Sergio Giralt
Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(12):1401-7.
2008: Michael Wang; Keith D Burau; Shenying Fang; Harry Wang; Xianglin L Du
Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma.
Cancer 2008;113(11):3231-41.
2008: Michael Wang; Meletios A Dimopoulos; Christine Chen; M Teresa Cibeira; Michel Attal; Andrew Spencer; S Vincent Rajkumar; Zhinuan Yu; Marta Olesnyckyj; Jerome B Zeldis; Robert D Knight; Donna M Weber
Lenalidomide plus dexamethasone is more effective than dexamethasone alone in patients with relapsed or refractory multiple myeloma regardless of prior thalidomide exposure.
Blood 2008;112(12):4445-51.
2008: Michael Wang; Luis Fayad; Fernando Cabanillas; Fredrick Hagemeister; Peter McLaughlin; Maria A Rodriguez; Larry W Kwak; Yuhong Zhou; Andrew Lamb; Jorge Romaguera
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.
Cancer 2008;113(10):2734-41.
2008: Yuhong Zhou; Haijun Wang; Wenjing Fang; Jorge E Romaguer; Yanxia Zhang; Kay Delasalle; Larry W Kwak; Qing Yi; Xianglin L Du; Michael Wang
Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004.
Cancer 2008;113(4):791-8.
2008: Michael Wang; Liang Zhang; Xiaohong Han; Jing Yang; Jianfei Qian; Sungyoul Hong; Pei Lin; Yuankai Shi; Jorge Romaguera; Larry W Kwak; Qing Yi
A severe combined immunodeficient-hu in vivo mouse model of human primary mantle cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(7):2154-60.
2007: Donna M Weber; Christine Chen; Ruben Niesvizky; Michael Wang; Andrew Belch; Edward A Stadtmauer; David Siegel; Ivan Borrello; S Vincent Rajkumar; Asher Chanan-Khan; Sagar Lonial; Zhinuan Yu; John Patin; Marta Olesnyckyj; Jerome B Zeldis; Robert D Knight
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America.
The New England journal of medicine 2007;357(21):2133-42.
2007: Jing Yang; Xiang Zhang; Ji Wang; Jianfei Qian; Liang Zhang; Michael Wang; Larry W Kwak; Qing Yi
Anti beta2-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid rafts.
Blood 2007;110(8):3028-35.
2007: Jing Yang; Michele Wezeman; Xiang Zhang; Pei Lin; Michael Wang; Jianfei Qian; Bo Wan; Larry W Kwak; Long Yu; Qing Yi
Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis.
Cancer cell 2007;12(3):252-65.
2007: Muzaffar H Qazilbash; Rima M Saliba; Bilal Ahmed; Gaurav Parikh; Floralyn Mendoza; Noman Ashraf; Chitra Hosing; Thuy Flosser; Donna M Weber; Michael Wang; Daniel Couriel; Uday Popat; Partow Kebriaei; Amin Alousi; Paolo Anderlini; Rizwan C. Naeem; Richard E Champlin; Sergio Giralt
Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in myeloma patients undergoing an autotransplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(9):1066-72.
2007: Jianfei Qian; Jin Xie; Sungyoul Hong; Jing Yang; Liang Zhang; Xiaohong Han; Michael Wang; Fenghuang Zhan; John D Shaughnessy; Joshua Epstein; Larry W Kwak; Qing Yi
Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.
Blood 2007;110(5):1587-94.
2007: Nam H Dang; Luis Fayad; Peter McLaughlin; Jorge E Romaguara; Fredrick Hagemeister; Andre Goy; Sattva S Neelapu; Felipe Samaniego; Pamela L Walker; Michael Wang; Maria A Rodriguez; Ann T Tong; Barbara Pro
Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma.
British journal of haematology 2007;138(4):502-5.
2007: Michael Wang; Liang Zhang; Xiaohong Han; Jing Yang; Jianfei Qian; Sungyoul Hong; Felipe Samaniego; Jorge Romaguera; Qing Yi
Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways.
Blood 2007;109(12):5455-62.
2007: Michael Wang; Sergio Giralt; Kay Delasalle; Beverly C Handy; Raymond Alexanian
Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myeloma.
Hematology (Amsterdam, Netherlands) 2007;12(3):235-9.
2007: Muzaffar H Qazilbash; Rima M Saliba; Chitra Hosing; Floralyn Mendoza; S R Qureshi; Donna M Weber; Michael Wang; T Flosser; Daniel Couriel; Marcos De Lima; Partow Kebriaei; Uday Popat; Amin Alousi; Richard E Champlin; Sergio Giralt
Autologous stem cell transplantation is safe and feasible in elderly patients with multiple myeloma.
Bone marrow transplantation 2007;39(5):279-83.
2007: Ellen C Mullen; Michael Wang
Recognizing hyperviscosity syndrome in patients with Waldenstrom macroglobulinemia.
Clinical journal of oncology nursing 2007;11(1):87-95.
2006: Amar Safdar; Maria A Rodriguez; Luis Fayad; Gilhen H Rodriguez; Barbara Pro; Michael Wang; Jorge Romaguera; Andre Goy; Fredrick B Hagemeister; Peter McLaughlin; Gerald P Bodey; Larry W Kwak; Issam I Raad; Robert B Couch
Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma.
The Journal of infectious diseases 2006;194(10):1394-7.
2006: Anas Younes; Luis Fayad; Jorge Romaguera; Barbara Pro; Andre Goy; Michael Wang
Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphoma.
European journal of cancer (Oxford, England : 1990) 2006;42(17):2976-81.
2006: Jing Yang; Jianfei Qian; Michele Wezeman; Siqing Wang; Pei Lin; Michael Wang; Shmuel Yaccoby; Larry W Kwak; Bart Barlogie; Qing Yi
Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies.
Cancer cell 2006;10(4):295-307.
2006: Michael Wang; Yuhong Zhou; Liang Zhang; C Ann Nguyen; Jorge Romaguera
Use of bortezomib in B-cell non-Hodgkin's lymphoma.
Expert review of anticancer therapy 2006;6(7):983-91.
2005: Jorge Romaguera; Luis Fayad; Maria A Rodriguez; Kristine Broglio; Fredrick B Hagemeister; Barbara Pro; Peter McLaughlin; Anas Younes; Felipe Samaniego; Andre Goy; Andreas H Sarris; Nam H Dang; Michael Wang; Virginia Beasley; L Jeffrey Medeiros; Ruth Katz; Harish K Gagneja; Barry Samuels; Terry L Smith; Fernando Cabanillas
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7013-23.
2005: M Amit-Vazina; Shishir Shishodia; David Harris; Quin Van; Michael Wang; Donna Weber; Raymond Alexanian; Moshe Talpaz; Bharat B Aggarwal; Zeev Estrov
Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells.
British journal of cancer 2005;93(1):70-80.
2005: Michael Wang; Donna M Weber; Kay Delasalle; Raymond Alexanian
Thalidomide-dexamethasone as primary therapy for advanced multiple myeloma.
American journal of hematology 2005;79(3):194-7.
2005: Andre Goy; Anas Younes; Peter McLaughlin; Barbara Pro; Jorge Romaguera; Fredrick Hagemeister; Luis Fayad; Nam H Dang; Felipe Samaniego; Michael Wang; Kristine Broglio; Barry Samuels; Frederic Gilles; Andreas H Sarris; Susan Hart; Elizabeth Trehu; David P Schenkein; Fernando Cabanillas; Alma M Rodriguez
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(4):667-75.
2004: Nam H Dang; Fredrick B Hagemeister; Barbara Pro; Peter McLaughlin; Jorge Romaguera; Dan Jones; Barry Samuels; Felipe Samaniego; Anas Younes; Michael Wang; Andre Goy; Maria A Rodriguez; Pamela L Walker; Yolanda Arredondo; Ann T Tong; Luis Fayad
Phase II study of denileukin diftitox for relapsed/refractory B-Cell non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(20):4095-102.
2004: Zhiyong Li; Nuhad K Ibrahim; J Kyle Wathen; Michael Wang; Rosario P Mante Menchu; Vicente Valero; Richard Theriault; Aman U Buzdar; Gabriel N Hortobagyi
Colitis in patients with breast carcinoma treated with taxane-based chemotherapy.
Cancer 2004;101(7):1508-13.
2003: Raymond Alexanian; Donna Weber; Athanasios Anagnostopoulos; Kay Delasalle; Michael Wang; Kim Rankin
Thalidomide with or without dexamethasone for refractory or relapsing multiple myeloma.
Seminars in hematology 2003;40(4 Suppl 4):3-7.
2003: John L Clifford; Xiulan Yang; Eugene Walch; Michael Wang; Scott M Lippman
Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon alpha action in skin squamous cell carcinoma cells.
Molecular cancer therapeutics 2003;2(5):453-9.